Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant

被引:115
作者
Faute, MAD
Laurent, L
Ploton, D
Poupon, MF
Jardillier, JC
Bobichon, H
机构
[1] Inst Curie, CNRS, UMR 147, F-75231 Paris, France
[2] Fac Pharm, IFR 53, EA 2063, Reims, France
[3] Fac Odontol, IFR 53, Reims, France
[4] Fac Pharm, IFR 53, FRE 2141, Reims, France
关键词
drug resistance; invasiveness; junctions; MCF-7; spheroids;
D O I
10.1023/A:1014594825502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Growth of human tumor cells as three-dimensional (3D) multicellular spheroids modifies their invasive properties. Here we study the differences in the biological features of MCF-7, a human breast cancer cell line, and its multidrug resistant variant (MDR-MCF-7) cultured as spheroids or as monolayers. Three-dimensional culture decreased the proliferative rate of both cell lines, reduced the drug sensitivity of MCF-7 cells and did not affect the resistance of MDR-MCF-7 cells. Transmission electron microscopic studies and intercellular junctions labeling showed that MCF-7 spheroids had a junctional system involving E-cadherin, tight-junctions and desmosomes. In MDR-MCF-7 cell spheroids, cell cohesion was mostly due to membrane interdigitations. MDR-MCF-7 cells, but not their parental counterpart, displayed a higher invasive potential when cultured as spheroids, as shown in the Boyden chamber assay. 3D-induced invasiveness was correlated with serine protease and plasminogen activator (PA) secretion. MCF-7 cells did not show any tendency to invade, whatever the mode of culture. These results show that 3D-cultures as spheroids distinctively altered structural features of parental and MDR-MCF-7 cells. In MCF-7 cells, 3D-culture increased cell-cell contacts and drug resistance; in MDR-MCF-7 cells, it induced invasive properties.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 29 条
[1]  
ALBINI A, 1987, CANCER RES, V47, P3239
[2]   ASPECTS OF THE CELLULAR PHARMACOLOGY OF N-L-LEUCYLDOXORUBICIN IN HUMAN TUMOR-CELL LINES [J].
BENNIS, S ;
GARCIA, C ;
ROBERT, J .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) :1929-1931
[3]   CADHERIN EXPRESSION IN CARCINOMAS - ROLE IN THE FORMATION OF CELL-JUNCTIONS AND THE PREVENTION OF INVASIVENESS [J].
BIRCHMEIER, W ;
BEHRENS, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :11-26
[4]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[5]   CHEMOSENSITIVITY TESTING OF SMALL-CELL LUNG-CANCER USING THE MTT ASSAY [J].
CAMPLING, BG ;
PYM, J ;
BAKER, HM ;
COLE, SPC ;
LAM, YM .
BRITISH JOURNAL OF CANCER, 1991, 63 (01) :75-83
[6]  
Dangles V, 1997, CANCER RES, V57, P3360
[7]  
Davies G, 1998, ONCOL REP, V5, P1567
[8]  
ENGERS R, IN VITRO INVASIVENES
[9]   Critical determinants of cancer metastasis: rationale for therapy [J].
Fidler, IJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) :S3-S10
[10]  
Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO